CA - Cipher Pharmaceuticals (CPHRF) Q4 2023 Earnings Call Transcript
2024-03-15 10:33:04 ET
Cipher Pharmaceuticals Inc. (CPHRF)
Q4 2023 Earnings Conference Call
March 15, 2024 8:30 am ET
Company Participants
Craig Mull - Chief Executive Officer (interim)
Bryan Jacobs - Chief Financial Officer
Conference Call Participants
André Uddin - Research Capital
Justin Keywood - Stifel
Dean Trottier - private investor
Presentation
Operator
Good morning ladies and gentlemen. Thank you for standing by. Welcome to the Cipher Pharmaceuticals fourth quarter and full year 2023 results conference call.
At this time, all participants are in a listen-only mode. Following today’s presentation, instructions will be given for the question and answer session. If anyone needs assistance at any time during the call, you may press star followed by zero on your pushbutton phone. As a reminder, this conference is being recorded today, Friday, March 15, 2024.
On behalf of the speakers that follow, listeners are cautioned that today’s presentation and the responses to questions may contain forward-looking statements within the meaning of the Safe Harbor provisions of the Canadian provincial securities laws. Forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are implied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements....
Cipher Pharmaceuticals (CPHRF) Q4 2023 Earnings Call Transcript